SCHOTT Pharma
Florian Leimeister has extensive experience in IT and project management. Florian is currently serving as the Head of Information Technology EMEA at SCHOTT Pharma since 2022. Prior to this, they held various roles at SCHOTT, including Head of Information Technology Pharmaceutical Systems EMEA and Senior Manager Projects & IT EMEA Pharmaceutical Systems. Florian also worked as an IT Projektleiter at Glaub GmbH from 2012 to 2015, and as an IT Projektleiter at CASE Deutschland from 2010 to 2012. Florian started their career as a Diplomand at SAP in 2010 and previously worked as an Entwickler at DLR and a Praktikant at Robert Bosch GmbH.
Florian Leimeister obtained a Diplom Informatiker (FH) in Informatik from Ostfalia - Hochgschule f. angewandte Wissenschaften from 2005 to 2010. In 2014, they received an ITIL® Foundation Certificate in IT Service Management. Additionally, Florian Leimeister is a certified project manager (GPM / IPMA Level C) from GPM/IPMA. Florian is also pursuing an Advanced Leadership certification from Management School St.Gallen, to be obtained in 2023.
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social